DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $150 | -98.1% | 608 | +1926.7% | 0.00% | – |
| Q2 2022 | $8,000 | -11.1% | 30 | 0.0% | 0.00% | – |
| Q1 2022 | $9,000 | -90.4% | 30 | -89.5% | 0.00% | -100.0% |
| Q4 2021 | $94,000 | +118.6% | 285 | +103.6% | 0.00% | – |
| Q3 2021 | $43,000 | +16.2% | 140 | +2.9% | 0.00% | – |
| Q2 2021 | $37,000 | +19.4% | 136 | 0.0% | 0.00% | – |
| Q1 2021 | $31,000 | +3.3% | 136 | 0.0% | 0.00% | – |
| Q4 2020 | $30,000 | -97.8% | 136 | -97.8% | 0.00% | -100.0% |
| Q3 2020 | $1,353,000 | -34.8% | 6,282 | -46.4% | 0.02% | -44.1% |
| Q2 2020 | $2,074,000 | +89.6% | 11,726 | +48.4% | 0.03% | +36.0% |
| Q1 2020 | $1,094,000 | -27.8% | 7,901 | -20.0% | 0.02% | -13.8% |
| Q4 2019 | $1,515,000 | +23.4% | 9,871 | +16.1% | 0.03% | +16.0% |
| Q3 2019 | $1,228,000 | +44.1% | 8,502 | +42.7% | 0.02% | +13.6% |
| Q2 2019 | $852,000 | +21.9% | 5,958 | +12.5% | 0.02% | +29.4% |
| Q1 2019 | $699,000 | +703.4% | 5,295 | +527.4% | 0.02% | +750.0% |
| Q4 2018 | $87,000 | -84.4% | 844 | -83.6% | 0.00% | -83.3% |
| Q3 2018 | $558,000 | +215.3% | 5,139 | +186.9% | 0.01% | +200.0% |
| Q2 2018 | $177,000 | +3440.0% | 1,791 | +3098.2% | 0.00% | – |
| Q1 2018 | $5,000 | -89.6% | 56 | -90.1% | 0.00% | -100.0% |
| Q2 2017 | $48,000 | -2.0% | 567 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $49,000 | +11.4% | 567 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $44,000 | – | 567 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |